Next Generation Sequencing (NGS) Market categories the global market by Platforms (MiSeq, Illumina HiSeq, 454 Roche, Life Technologies Ion Proton/PGM, by Bioinformatics (RNA-Seq, ChIP-Seq), & by Geography
[350 Pages Report] Next Generation Sequencing (NGS) Market categories the global market by Platforms (MiSeq, Illumina HiSeq, 454 Roche, Life Technologies Ion Proton/PGM, by Bioinformatics (RNA-Seq, ChIP-Seq), & by Geography
[350 Pages Report] Next Generation Sequencing (NGS) Market categories the global market by Platforms (MiSeq, Illumina HiSeq, 454 Roche, Life Technologies Ion Proton/PGM, by Bioinformatics (RNA-Seq, ChIP-Seq), (SBS, SMRT & Pyrosequencing,), (Diagnostics, Personalized Medicine) & by Geography.
Global Next Generation Sequencing (NGS) Market,By Product (Instruments (Hiseq series, Miseq series, ION Torrent, SOLiD, Pacbio Rs II and Sequel system), Consumables (Sample preparation consumables, Other), Services (Sequencing services, Data management services), by Application (Diagnostics, Drug Discovery , Biomarker Discovery , Precision Medicine , Agriculture & Animal Research), by End-user (Hospitals & Clinics, Research Centers and Academic & Government Institutes, and Pharmaceutical & Biotechnology Companies), by Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024
This report provided by GrandResearchStore is about,The global NGS market is expected to reach USD 10,371.1 million by 2021 from USD 4,031.7 million in 2016, at a CAGR of 20.8% between 2016 and 2021. North America is expected to hold the largest share of the global NGS market in 2016. The NGS market is broadly segmented into products & services, technology, application, and end user. By products & services, the NGS market is segmented into pre-sequencing products & services, NGS platforms, consumables, sequencing services, data analysis/bioinformatics. The consumables segment is expected to command the major share of the NGS market, by products& services, in 2016.
MedGenome Share Price will grow based on the company’s performance and on the current market conditions. MedGemome is a global leader in Genetic Testing services, Genomics Research, and drug discovery solutions. It operates a multi-pronged business model that capitalizes on the growing demand for personalized medicine and genetic insights. MedGenome has been committed to delivering world-class genomic solutions with greater precision and accuracy to empower every human being for better management of their health since 2013. MedGenome utilizes advanced technologies like Next-Generation Sequencing (NGS) for in-depth genetic analysis, aiding in complex diagnosis and personalized treatment plans. You can check the Planify website for the latest share price and news.
However, accuracy & standardization concerns in diagnostic testing, lack of skilled professionals, and ethical & legal issues related to NGS are some of the key factors restraining the growth of this market. In addition to this, challenges associated with interpretation of complex data from NGS platforms and storage of sequencing data also limits the growth of the NGS market.
This report broadly segments the global next generation sequencing market into products & services, technology, application, and end user. The NGS market, by products & services is segmented into pre-sequencing products & services, NGS platforms, consumables, sequencing services, data analysis/bioinformatics.
L. monocytogenes WHOLE GENOME SEQUENCING PROJECT * Whole Genome Sequencing improves Identification of persistent LM ... Use of Solexa chemistry for fluorescent ...
According to the Market Statsville Group (MSG), the global next generation sequencing market size is expected to grow from USD 9,345.0 million in 2022 to USD 58,254.4 million by 2033, at a CAGR of 18.1% from 2023 to 2033.
The global next generation sequencing market is geographically segmented into North America, Europe, Asia, and Rest of the World, with North America contributing the highest share, followed by Europe.
Metagenomics is the study of metagenomes, genetic material recovered directly from environmental samples. The broad field was referred to as environmental genomics, ecogenomics or community genomics. Recent studies use "shotgun" Sanger sequencing or next generation sequencing (NGS) to get largely unbiased samples of all genes from all the members of the sampled communities.
Next Generation Sequencing (NGS) Market is also termed as high-throughput sequencing. It is a DNA sequencing technology in which millions and billions DNA strands are sequenced. It has revolutionized genomic research, as it minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes.
Next Generation Sequencing (NGS) Market is also termed as high-throughput sequencing. It is a DNA sequencing technology in which millions and billions DNA strands are sequenced. It has revolutionized genomic research, as it minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes.
Next Generation Sequencing (NGS) Market is also termed as high-throughput sequencing. It is a DNA sequencing technology in which millions and billions DNA strands are sequenced. It has revolutionized genomic research, as it minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes.
iGATE Research has released a research report on “Global Next Generation Sequencing (NGS) Market (By Products - Consumables, Platforms, Services, Sequencing Services, Bioinformatics, Technology, Applications, End Users, Regions), Key Company Profiles - Forecast to 2025” Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=165 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
The report "Genomics Market by Product (Instruments, Consumables), by Technology (Sequencing, PCR, Microarray), by Application (Diagnostics, Personalized Medicine), by Process (Library Preparation, Sequencing & Imaging), by End User - Trends & Global Forecasts to 2020" , analyzes and studies the major market drivers, restraints/challenges, and opportunities.
According to a new market research study titled ‘Epigenetics Market to 2025 - Global Analysis and Forecasts by Product, Technology, Application and End User. The global epigenetics market is expected to reach US$ 2,611.57 Mn in 2025 from US$ 991.45 in 2017. The market is estimated to grow with a CAGR of 13.6% from 2018-2025. The report highlights the trends prevalent in the global epigenetics market and the factors driving the market along with those that act as deterrents to its growth.
“The future of genomics lies in the personalized medicine industry. Government initiatives and considerable investments are expected to drive genetic research on personalized medicines that utilize base pairs of the human genome sequence”.
The report segments the Global Genomics market by products (instrument, consumables, and services), by technology (Nucleic acid extraction & purification, PCR, DNA sequencing, and DNA microarray), by application (diagnostics, personalized medicine, academic research, agriculture & animal health, and academic research), and by geography (North America, Europe, APAC, and RoW).
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPHE100000820 According to a new market research study titled 'Next Generation Sequencing Market to 2025 - Global Analysis and Forecasts by Product, Services, Applications, and End-Users, the global next generation sequencing market was valued at US$ 5,731.3 Mn in 2017 and is estimated to reach US$ 26,501.2 Mn by 2025. The report highlights the trends prevalent in the global next generation sequencing market and the factors driving the market along with those that act as deterrents to its growth.
RNA-Seq and Transcriptome Analysis Jessica R. Kirkpatrick, M.S. Research & Instructional Specialist in Life Sciences High Performance Biological Computing (HPCBio)
Though most of healthcare solution providers are still evolving, there are larger drifts growing in healthcare, emergency services, pathology, and various among other things. Here in this special issue of ‘Emerging Healthcare Solution Providers to Watch in 2019’, we have enlightened the foremost Healthcare Solution Providers that are transforming the healthcare industry with their astounding services and approaches.
The global next-generation sequencing market is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach USD 12.45 billion by 2022. Download Sample at http://bit.ly/2zigGOc . Factors such as technological advancements in NGS platforms, increasing applications of NGS, growing partnerships and collaborations, and increasing adoption of NGS among research laboratories and academic institutes are driving the growth of this market.
The high growth in this segment can be attributed to the development of advanced NGS-based diagnostic solutions and growing number of agreements between companies and hospitals for developing advanced tests and products catering to the specific needs of hospitals and clinics.